 Elizabeth Gillespie
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disinfection | 7 | 2017 | 124 | 2.430 |
Why?
| | Infection Control | 12 | 2016 | 167 | 2.330 |
Why?
| | Housekeeping, Hospital | 5 | 2019 | 6 | 2.310 |
Why?
| | Cross Infection | 11 | 2022 | 256 | 2.270 |
Why?
| | Disease Outbreaks | 8 | 2017 | 395 | 1.530 |
Why?
| | Equipment Contamination | 6 | 2016 | 67 | 1.480 |
Why?
| | Environmental Microbiology | 4 | 2015 | 53 | 1.380 |
Why?
| | Decontamination | 2 | 2016 | 30 | 0.970 |
Why?
| | Health Facilities | 3 | 2015 | 84 | 0.930 |
Why?
| | Steam | 5 | 2017 | 15 | 0.920 |
Why?
| | Sterilization | 2 | 2014 | 23 | 0.860 |
Why?
| | Intensive Care Units | 4 | 2015 | 832 | 0.840 |
Why?
| | Safety-net Providers | 1 | 2024 | 119 | 0.820 |
Why?
| | Operating Rooms | 2 | 2015 | 123 | 0.790 |
Why?
| | Hot Temperature | 2 | 2024 | 391 | 0.780 |
Why?
| | Allergists | 1 | 2022 | 12 | 0.750 |
Why?
| | Gram-Positive Bacterial Infections | 3 | 2017 | 70 | 0.690 |
Why?
| | Vancomycin-Resistant Enterococci | 2 | 2017 | 10 | 0.650 |
Why?
| | Environmental Exposure | 1 | 2024 | 579 | 0.650 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 807 | 0.570 |
Why?
| | Australia | 7 | 2017 | 315 | 0.550 |
Why?
| | Cost-Benefit Analysis | 3 | 2016 | 593 | 0.540 |
Why?
| | Duodenoscopes | 1 | 2016 | 7 | 0.520 |
Why?
| | Public Health | 1 | 2022 | 588 | 0.520 |
Why?
| | Disease Transmission, Infectious | 1 | 2017 | 62 | 0.510 |
Why?
| | Medical Waste Disposal | 1 | 2016 | 1 | 0.500 |
Why?
| | Luminescent Measurements | 1 | 2016 | 76 | 0.500 |
Why?
| | Enterobacteriaceae Infections | 1 | 2016 | 43 | 0.500 |
Why?
| | Bedding and Linens | 1 | 2016 | 11 | 0.500 |
Why?
| | Maintenance and Engineering, Hospital | 1 | 2015 | 2 | 0.470 |
Why?
| | Durable Medical Equipment | 1 | 2015 | 5 | 0.470 |
Why?
| | Bacteremia | 3 | 2022 | 214 | 0.460 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 2016 | 213 | 0.440 |
Why?
| | Patient Isolation | 1 | 2014 | 19 | 0.430 |
Why?
| | Disposable Equipment | 1 | 2014 | 19 | 0.430 |
Why?
| | Adenosine Triphosphate | 1 | 2016 | 491 | 0.430 |
Why?
| | Silver | 1 | 2014 | 38 | 0.420 |
Why?
| | Disinfectants | 1 | 2014 | 39 | 0.420 |
Why?
| | Fluorescent Dyes | 2 | 2014 | 321 | 0.420 |
Why?
| | Perioperative Nursing | 1 | 2013 | 7 | 0.410 |
Why?
| | Anti-Infective Agents | 1 | 2016 | 256 | 0.400 |
Why?
| | Staphylococcal Infections | 3 | 2022 | 400 | 0.400 |
Why?
| | Environmental Monitoring | 1 | 2015 | 370 | 0.400 |
Why?
| | Sutures | 1 | 2013 | 58 | 0.390 |
Why?
| | Hair | 1 | 2013 | 86 | 0.380 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 307 | 0.380 |
Why?
| | Drug Therapy | 1 | 2012 | 85 | 0.380 |
Why?
| | Hand Disinfection | 3 | 2013 | 27 | 0.370 |
Why?
| | Health Personnel | 2 | 2015 | 711 | 0.360 |
Why?
| | Reference Standards | 1 | 2011 | 186 | 0.350 |
Why?
| | Climate Change | 2 | 2024 | 183 | 0.340 |
Why?
| | Bacterial Infections | 1 | 2012 | 250 | 0.330 |
Why?
| | Victoria | 8 | 2022 | 18 | 0.330 |
Why?
| | Nurses | 1 | 2012 | 180 | 0.320 |
Why?
| | Guideline Adherence | 3 | 2008 | 556 | 0.300 |
Why?
| | Humans | 36 | 2024 | 137782 | 0.290 |
Why?
| | Methicillin Resistance | 2 | 2008 | 18 | 0.290 |
Why?
| | Medical Staff, Hospital | 2 | 2008 | 83 | 0.280 |
Why?
| | Equipment Reuse | 1 | 2007 | 16 | 0.280 |
Why?
| | Endoscopes | 1 | 2007 | 17 | 0.280 |
Why?
| | Chlorhexidine | 1 | 2007 | 24 | 0.270 |
Why?
| | Bacteria | 1 | 2014 | 858 | 0.270 |
Why?
| | Anti-Infective Agents, Local | 1 | 2007 | 40 | 0.270 |
Why?
| | Serratia Infections | 1 | 2007 | 8 | 0.260 |
Why?
| | Serratia marcescens | 1 | 2007 | 16 | 0.260 |
Why?
| | Clostridium Infections | 2 | 2022 | 73 | 0.260 |
Why?
| | Homes for the Aged | 3 | 2017 | 34 | 0.260 |
Why?
| | Nursing Staff, Hospital | 2 | 2008 | 162 | 0.250 |
Why?
| | Influenza, Human | 2 | 2014 | 622 | 0.250 |
Why?
| | Staphylococcus aureus | 3 | 2022 | 450 | 0.250 |
Why?
| | Endoscopy | 1 | 2007 | 318 | 0.230 |
Why?
| | Attitude of Health Personnel | 2 | 2012 | 1172 | 0.210 |
Why?
| | Anti-Bacterial Agents | 2 | 2016 | 1809 | 0.200 |
Why?
| | Carrier State | 2 | 2015 | 67 | 0.200 |
Why?
| | Quality of Health Care | 1 | 2007 | 642 | 0.200 |
Why?
| | Time Factors | 4 | 2016 | 6834 | 0.190 |
Why?
| | Extreme Heat | 1 | 2022 | 6 | 0.190 |
Why?
| | International Classification of Diseases | 1 | 2022 | 135 | 0.180 |
Why?
| | Colony Count, Microbial | 2 | 2014 | 120 | 0.180 |
Why?
| | Heat Stress Disorders | 1 | 2022 | 76 | 0.180 |
Why?
| | Internal Medicine | 1 | 2024 | 269 | 0.180 |
Why?
| | Societies, Medical | 1 | 2024 | 820 | 0.160 |
Why?
| | Safety Management | 1 | 2019 | 124 | 0.140 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2860 | 0.130 |
Why?
| | Parainfluenza Virus 3, Human | 1 | 2016 | 5 | 0.130 |
Why?
| | Respirovirus Infections | 1 | 2016 | 13 | 0.130 |
Why?
| | Textiles | 1 | 2017 | 22 | 0.130 |
Why?
| | Aged | 8 | 2024 | 24001 | 0.130 |
Why?
| | Bacteriological Techniques | 1 | 2017 | 73 | 0.130 |
Why?
| | Medical Waste | 1 | 2016 | 1 | 0.130 |
Why?
| | Gram-Positive Bacteria | 1 | 2016 | 48 | 0.120 |
Why?
| | Gram-Negative Bacteria | 1 | 2016 | 73 | 0.120 |
Why?
| | Environment, Controlled | 1 | 2015 | 22 | 0.120 |
Why?
| | Enterococcus faecium | 1 | 2015 | 20 | 0.120 |
Why?
| | Quality Control | 1 | 2015 | 172 | 0.120 |
Why?
| | Urinary Tract Infections | 1 | 2017 | 188 | 0.120 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 515 | 0.110 |
Why?
| | Enterococcus | 2 | 2011 | 23 | 0.110 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1002 | 0.110 |
Why?
| | Quality Improvement | 1 | 2022 | 1181 | 0.110 |
Why?
| | Equipment and Supplies, Hospital | 1 | 2013 | 5 | 0.100 |
Why?
| | Masks | 1 | 2014 | 63 | 0.100 |
Why?
| | Caliciviridae Infections | 1 | 2013 | 20 | 0.100 |
Why?
| | Norovirus | 1 | 2013 | 26 | 0.100 |
Why?
| | Floors and Floorcoverings | 1 | 2012 | 4 | 0.100 |
Why?
| | Enterobacteriaceae | 1 | 2013 | 40 | 0.100 |
Why?
| | Infant, Newborn | 3 | 2017 | 6084 | 0.100 |
Why?
| | Drug Resistance, Microbial | 1 | 2013 | 71 | 0.100 |
Why?
| | Gastroenteritis | 1 | 2013 | 69 | 0.100 |
Why?
| | Catheter-Related Infections | 1 | 2013 | 92 | 0.090 |
Why?
| | Catheterization, Peripheral | 1 | 2013 | 109 | 0.090 |
Why?
| | Ultraviolet Rays | 1 | 2014 | 396 | 0.090 |
Why?
| | Professional Competence | 1 | 2012 | 100 | 0.090 |
Why?
| | Polymers | 1 | 2015 | 490 | 0.090 |
Why?
| | Education, Medical, Continuing | 1 | 2012 | 128 | 0.090 |
Why?
| | Retrospective Studies | 3 | 2024 | 15682 | 0.090 |
Why?
| | Male | 11 | 2024 | 67906 | 0.090 |
Why?
| | Staining and Labeling | 1 | 2011 | 151 | 0.090 |
Why?
| | Escherichia coli Infections | 1 | 2011 | 111 | 0.090 |
Why?
| | Hospitals | 1 | 2016 | 691 | 0.090 |
Why?
| | Middle Aged | 5 | 2024 | 33554 | 0.090 |
Why?
| | Pilot Projects | 2 | 2014 | 1713 | 0.090 |
Why?
| | Environment | 1 | 2012 | 358 | 0.080 |
Why?
| | Drug Resistance, Bacterial | 1 | 2011 | 186 | 0.080 |
Why?
| | Adolescent | 3 | 2024 | 21574 | 0.080 |
Why?
| | Female | 10 | 2024 | 73465 | 0.080 |
Why?
| | Child, Preschool | 1 | 2024 | 11105 | 0.080 |
Why?
| | Nursing Homes | 1 | 2011 | 181 | 0.080 |
Why?
| | Young Adult | 2 | 2024 | 13240 | 0.080 |
Why?
| | Bacterial Proteins | 1 | 2015 | 879 | 0.080 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2015 | 257 | 0.080 |
Why?
| | Skin Care | 1 | 2008 | 25 | 0.080 |
Why?
| | Influenza Vaccines | 1 | 2014 | 539 | 0.070 |
Why?
| | Health Services Research | 1 | 2011 | 404 | 0.070 |
Why?
| | Infectious Disease Transmission, Professional-to-Patient | 1 | 2008 | 5 | 0.070 |
Why?
| | Adult | 4 | 2024 | 38023 | 0.070 |
Why?
| | Neoplasms | 1 | 2022 | 2673 | 0.070 |
Why?
| | Vaccination | 1 | 2014 | 1381 | 0.060 |
Why?
| | Delivery of Health Care | 2 | 2022 | 951 | 0.060 |
Why?
| | Electronic Health Records | 2 | 2022 | 1070 | 0.060 |
Why?
| | Seasons | 1 | 2007 | 547 | 0.050 |
Why?
| | Critical Care | 1 | 2008 | 610 | 0.050 |
Why?
| | Practice Guidelines as Topic | 2 | 2008 | 1586 | 0.050 |
Why?
| | Diagnosis-Related Groups | 1 | 2022 | 31 | 0.050 |
Why?
| | Tertiary Care Centers | 2 | 2014 | 160 | 0.050 |
Why?
| | Arizona | 1 | 2022 | 81 | 0.050 |
Why?
| | Education, Medical | 1 | 2024 | 266 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 500 | 0.040 |
Why?
| | Risk Factors | 3 | 2022 | 10407 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2016 | 7637 | 0.030 |
Why?
| | Curriculum | 1 | 2024 | 996 | 0.030 |
Why?
| | Pneumonia | 1 | 2022 | 639 | 0.030 |
Why?
| | Epidemiological Monitoring | 1 | 2016 | 63 | 0.030 |
Why?
| | Incidence | 2 | 2013 | 2804 | 0.030 |
Why?
| | Drug Utilization | 1 | 2016 | 169 | 0.030 |
Why?
| | Multilocus Sequence Typing | 1 | 2015 | 16 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2016 | 242 | 0.030 |
Why?
| | Molecular Epidemiology | 1 | 2015 | 68 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2007 | 5793 | 0.030 |
Why?
| | Genome, Bacterial | 1 | 2015 | 142 | 0.030 |
Why?
| | Population Surveillance | 1 | 2017 | 482 | 0.030 |
Why?
| | Carbapenems | 1 | 2013 | 24 | 0.030 |
Why?
| | beta-Lactamases | 1 | 2013 | 48 | 0.020 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2013 | 46 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2013 | 329 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 812 | 0.020 |
Why?
| | beta-Lactam Resistance | 1 | 2011 | 8 | 0.020 |
Why?
| | Vancomycin Resistance | 1 | 2011 | 16 | 0.020 |
Why?
| | Immunization Programs | 1 | 2014 | 213 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2013 | 361 | 0.020 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2011 | 78 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1917 | 0.020 |
Why?
| | Medical Audit | 1 | 2008 | 78 | 0.020 |
Why?
| | Gram-Negative Aerobic Bacteria | 1 | 2008 | 5 | 0.020 |
Why?
| | Clothing | 1 | 2008 | 22 | 0.020 |
Why?
| | Hospital Units | 1 | 2008 | 29 | 0.020 |
Why?
| | United States | 1 | 2022 | 14870 | 0.010 |
Why?
| | Prevalence | 1 | 2011 | 2734 | 0.010 |
Why?
| | Risk Assessment | 1 | 2013 | 3461 | 0.010 |
Why?
| | Infant | 1 | 2015 | 9482 | 0.010 |
Why?
| | Prospective Studies | 1 | 2013 | 7623 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 5478 | 0.010 |
Why?
|
|
Gillespie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|